Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02446405 |
|---|---|
| Brief Title: | Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer (ENZAMET) |
| First Submitted : | May 4, 2015 |
| First Submitted that Met QC Criteria : | May 13, 2015 |
| First Posted : | May 18, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | November 24, 2022 |
| Last Update Posted : | November 30, 2022 |